Lv1
30 积分 2023-05-07 加入
EValuating trEatment RESponses of dupilumab versus omalizumab in Type 2 patients: the EVEREST Trial
2个月前
已完结
TREM2 macrophages drive NK cell paucity and dysfunction in lung cancer
1年前
已完结
Dopamine inhibits group 2 innate lymphoid cell-driven allergic lung inflammation by dampening mitochondrial activity
1年前
已完结
Steroid-induced fibroblast growth factors drive an epithelial-mesenchymal inflammatory axis in severe asthma
1年前
已完结
皖公网安备34019202002308
